
Stryker (SYK) Stock Forecast & Price Target
Stryker (SYK) Analyst Ratings
Bulls say
Stryker is seen as a strong player in the medical technology industry, with a track record of successful M&A activities and a diverse portfolio of products in various healthcare sectors. Despite facing a cyber incident, the company's financial performance remains strong, with projected revenue growth and earnings above consensus. However, there are risks involved in increasing borrowing for future M&A opportunities, and recent acquisitions have not had a significant impact on top-line growth.
Bears say
Stryker is a medical technology company that operates under MedSurg and Neurotechnology, and Orthopaedics and Spine segments. However, with an outlook of -2.21%, despite their diversified revenue composition, consistent execution, and leading position in orthopedic robotics, the recent cyber incident and lower than expected financial performance are potential risks that may impact the company's growth and margins, leading to a negative outlook.
This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.
Stryker (SYK) Analyst Forecast & Price Prediction
Start investing in Stryker (SYK)
Order type
Buy in
Order amount
Est. shares
0 shares